EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic deletion of Alx/Fpr2 differentially regulates pulmonary inflammation in the absence and presence of acute lung injury

Rafia Virk iD, Madeline Behee, Abrar Al-Shaer, Megan Wagner, Michael Armstrong, Nichole Reisdorph, Brooke Bathon, Nari Beatty, Traci Davis, Michael J Yaeger, Rosemary S Gray, Meagan D Bridges und 2 weitere

ImmunoHorizons · 2025

DOI: 10.1093/immhor/vlaf043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ImmunoHorizons, 2025. Verfasst von Rafia Virk und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Gillings School of Global Public Health and School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill…. Hauptthemen laut MEDLINE: Acute Lung Injury, Receptors, Formyl Peptide, Pneumonia, Receptors, Lipoxin. Die Arbeit nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIEHS NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The inflammation resolution receptor lipoxin A4/formyl peptide receptor 2 (ALX/FPR2) plays a critical role in immune regulation by binding select oxylipins derived from n-6 and n-3 polyunsaturated fatty acids (PUFAs). While ALX/FPR2 is implicated in controlling inflammation initiation and resolution, its specific role in pulmonary inflammatory responses remains unclear. In this study, we investigated how genetic deletion of Alx/Fpr2 controls oxylipin levels, immune cell populations, and inflammatory cytokines under conditions of homeostasis and injury. Alx/Fpr2 knockout (KO) mice exhibited normal food intake and weight gain but showed impaired glucose and lipid metabolism. Targeted lipidomic analyses by liquid chromatography–tandem mass spectrometry revealed elevated pulmonary concentrations of n-6 and n-3 PUFA–derived oxylipins in KO mice compared to controls. Flow cytometry further demonstrated increased lung infiltration of NK cells, monocytes, and lymphoid cells, indicating a proinflammatory state in the absence of injury. Following 24 h of LPS-induced acute lung injury, IL-1β levels were elevated in KO mice, but pulmonary histopathology, immune cell numbers, and oxylipin levels were comparable to those of controls. These results suggested a protective role of ALX/FPR2 upon acute lung injury, which led us to further investigate the role of ALX/FPR2 upon 72 h of lung injury. Indeed, Alx/Fpr2 KO mice showed reduced bronchoalveolar lavage protein concentration and lower levels of IL-6 and TNF-α. Collectively, these findings demonstrate that ALX/FPR2 deficiency promotes basal pulmonary inflammation but protects against prolonged injury-induced inflammation, highlighting the context-dependent role of this receptor in pulmonary inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjuryReceptors, Formyl PeptidePneumoniaReceptors, LipoxinAnimalsMiceMice, KnockoutLipopolysaccharidesLungMice, Inbred C57BLOxylipinsMaleCytokinesDisease Models, AnimalGene Deletion

Stichwörter der Autor:innen

inflammationlipid mediatorslipopolysaccharidelungrodent

Substanzen

Receptors, Formyl Peptideformyl peptide receptor 2, mouseLipopolysaccharidesOxylipinsReceptors, LipoxinCytokines

Autor:innen und Institutionen

  • Department of Nutrition, Gillings School of Global Public Health and School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Department of Pharmaceutical Sciences, University of Colorado Denver Anschutz Medical Campus, Aurora, CO, United States.
  • Division of Pulmonary, Critical Care and Sleep Medicine, The Ohio State University, Columbus, OH, United States.

ORCID-Profile: Rafia Virk

Förderung

  • NHLBI NIH HHS
  • NIEHS NIH HHS
  • NIDDK NIH HHS
  • National Institutes of Health

Zitieren

APA

Virk, R., Behee, M., Al-Shaer, A., Wagner, M., Armstrong, M., Reisdorph, N., Bathon, B., Beatty, N., Davis, T., Yaeger, M. J., Gray, R. S., Bridges, M. D., Gowdy, K. M., & Shaikh, S. R. (2025). Genetic deletion of Alx/Fpr2 differentially regulates pulmonary inflammation in the absence and presence of acute lung injury. ImmunoHorizons. https://doi.org/10.1093/immhor/vlaf043

Vancouver

Virk R, Behee M, Al-Shaer A, Wagner M, Armstrong M, Reisdorph N, et al. Genetic deletion of Alx/Fpr2 differentially regulates pulmonary inflammation in the absence and presence of acute lung injury. ImmunoHorizons. 2025. doi:10.1093/immhor/vlaf043

BibTeX
@article{Virk2025,
  author = {Virk, Rafia and Behee, Madeline and Al-Shaer, Abrar and Wagner, Megan and Armstrong, Michael and Reisdorph, Nichole and Bathon, Brooke and Beatty, Nari and Davis, Traci and Yaeger, Michael J and Gray, Rosemary S and Bridges, Meagan D and Gowdy, Kymberly M and Shaikh, Saame Raza},
  title = {Genetic deletion of Alx/Fpr2 differentially regulates pulmonary inflammation in the absence and presence of acute lung injury},
  journal = {ImmunoHorizons},
  year = {2025},
  doi = {10.1093/immhor/vlaf043}
}
Kostenlos starten →